Yan, Taiqiang
Peking University People's Hospital
2 papers on CoChatORCID 0000-0003-3982-1052
Most cited papers
- Verified
Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial
Xie, L., Xu, J., Sun, X., Guo, W., Gu, J., Liu, K., Zheng, B., Ren, T., Huang, Y., Tang, X., et al. (2020) · Journal for ImmunoTherapy of Cancer
Sarcoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 145
- Verified
Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial
Xie, L., Xu, J., Sun, X., Tang, X., Yan, T., Yang, R., & Guo, W. (2019) · The Oncologist
Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments
Cited by 128
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free